The Effectiveness of Commercial Weight Loss Programmes
This study has been completed.
Sponsor:
University of Surrey
Collaborator:
British Broadcasting Corporation
Information provided by:
University of Surrey
ClinicalTrials.gov Identifier:
NCT00327821
First received: May 17, 2006
Last updated: July 20, 2006
Last verified: May 2003
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective is to compare the effectiveness of 4 different commercial weight-loss diets available to adults in the UK.
This is achieved with a 6 month multi-centre randomised unblinded controlled trial of
- Dr Atkins' New Diet Revolution,
- The slimFast Plan,
- The weight Watchers Pure Points Programme,
- Rosemary Conley's "Eat Yourself Slim" Diet & Fitness Plan.
- No diet (control)
Subjects are a community based sample of 300 (60 per group) otherwise healthy overweight and obese adults.
Main outcome measures are weight and body fat change over 6 months.
| Condition | Intervention |
|---|---|
|
Obesity |
Behavioral: calorie controlled diet |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | A Randomised Control Trial of Commercial Weight Loss Programme in a Community Based Sample of Obese Adults. |
Resource links provided by NLM:
Further study details as provided by University of Surrey:
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Body mass index (BMI) > 27 and < 40 kg/m2.
Exclusion Criteria:
- History of coronary heart disease
- Type 1 or Type 2 diabetes
- Renal, liver or respiratory failure
- Gout
- Taking lipid lowering or anti-hypertensive drugs
- History of obesity with known cause (i.e. Cushings disease, hypothyroidism)
- Previous gastric or weight loss surgery
- Taking any weight loss drug (including Orlistat or Sibutramine)
- Clinical depression
- Eating disorders
- Drug or alcohol abuse
- Any malabsorptive state (including lactose intolerance)
- Being treated for a malignancy
- Being pregnant
- Breastfeeding
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00327821
Locations
| United Kingdom | |
| University of Surrey | |
| Guildford, Surrey, United Kingdom, GU2 7XH | |
Sponsors and Collaborators
University of Surrey
British Broadcasting Corporation
Investigators
| Principal Investigator: | D J Millward, PhD | University of Surrey |
| Study Director: | H A Truby, PhD SRD | University of Surrey |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00327821 History of Changes |
| Other Study ID Numbers: | 107189 BBC |
| Study First Received: | May 17, 2006 |
| Last Updated: | July 20, 2006 |
| Health Authority: | United Kingdom: National Health Service |
Additional relevant MeSH terms:
|
Obesity Weight Loss Overnutrition Nutrition Disorders |
Overweight Body Weight Signs and Symptoms Body Weight Changes |
ClinicalTrials.gov processed this record on May 23, 2013